U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Gardasil 9
  1. Vaccines, Blood & Biologics

Gardasil 9

STN:   125508
Proper Name: Human Papillomavirus 9-valent Vaccine, Recombinant
Tradename: Gardasil 9
Manufacturer: Merck & CO., Inc.

Indications: 

Indicated in girls and women 9 through 45 years of age for the prevention of the following diseases:

  • Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. (1.1)
  • Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.1)

And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58:

  • Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS). (1.1)
  • Cervical intraepithelial neoplasia (CIN) grade 1. (1.1)
  • Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3. (1.1)
  • Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3. (1.1)
  • Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.1)

GARDASIL 9 is indicated in boys and men 9 through 45 years of age for the prevention of the following diseases:

  • Anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58. (1.2)
  • Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.2)

And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58:

  • Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.2)

Product Information

Supporting Documents